Sun Pharma and Zydus recall products in US market

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US due to manufacturing issues, as reported by the US Food and Drug Administration (USFDA). Sun Pharma is recalling nearly 10,000 bottles of Morphine Sulfate tablets for failing dissolution tests. Zydus is recalling 36,978 vials of Nelarabine Injection, used for certain cancers, due to failed impurity specifications. This recall affects a specific lot and was initiated on February 13, 2025. Both recalls are classified as Class II, indicating that exposure may cause temporary health issues, but serious consequences are unlikely. Indian pharmaceutical companies play a significant role in supplying medications to the US market.